These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32092353)

  • 1. Translational genomics for rare cancers: Challenges and opportunity.
    Tan AC; Huang PH
    Semin Cancer Biol; 2020 Apr; 61():iii-iv. PubMed ID: 32092353
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical genomics in rare cancer.
    Abbas-Aghababazadeh F; Mo Q; Fridley BL
    Semin Cancer Biol; 2020 Apr; 61():1-10. PubMed ID: 31437624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing challenges in the diagnosis and treatment of rare genetic diseases.
    Boycott KM; Ardigó D
    Nat Rev Drug Discov; 2018 Mar; 17(3):151-152. PubMed ID: 29242613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and solutions to the study of rare childhood tumors.
    Fair D; Potter SL; Venkatramani R
    Curr Opin Pediatr; 2020 Feb; 32(1):7-12. PubMed ID: 31789973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key challenges in the treatment of rare pediatric skeletal genetic disorders: from bench to bedside.
    Lorget F; Legeai-Mallet L
    Drug Discov Today; 2015 Jul; 20(7):781-3. PubMed ID: 25943098
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of research collaborations and consortia in rare cancers.
    Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
    Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Medicine: What's in it for Rare Diseases?
    Schee Genannt Halfmann S; Mählmann L; Leyens L; Reumann M; Brand A
    Adv Exp Med Biol; 2017; 1031():387-404. PubMed ID: 29214584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare cancers: a sea of opportunity.
    Boyd N; Dancey JE; Gilks CB; Huntsman DG
    Lancet Oncol; 2016 Feb; 17(2):e52-e61. PubMed ID: 26868354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment.
    Lotan Y; Merseburger AS
    Curr Opin Urol; 2017 Jan; 27(1):34. PubMed ID: 27902674
    [No Abstract]   [Full Text] [Related]  

  • 11. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 12. Spotlight on rare diseases.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):75. PubMed ID: 30683214
    [No Abstract]   [Full Text] [Related]  

  • 13. What Precision Medicine Can Learn from Rare Genetic Disease Research and Translation.
    Tabor HK; Goldenberg A
    AMA J Ethics; 2018 Sep; 20(9):E834-840. PubMed ID: 30242814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating Aboriginal genomics - four letters Closing the Gap.
    Baynam GS; Pearson G; Blackwell J
    Med J Aust; 2016 Oct; 205(8):379. PubMed ID: 27736627
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rare diseases in the age of genomics and precision medicine].
    Ríos-Leal JA; Labbé-Atenas TP
    Rev Med Chil; 2019 Apr; 147(4):530-531. PubMed ID: 31344219
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare diseases: Genomics, plain and simple.
    Gura T
    Nature; 2012 Feb; 483(7387):20-2. PubMed ID: 22382959
    [No Abstract]   [Full Text] [Related]  

  • 17. Biomarkers in Rare Diseases.
    Bax BE
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From gene to treatment: supporting rare disease translational research through model systems.
    Hmeljak J; Justice MJ
    Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30819728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Tumors in Children: Progress Through Collaboration.
    Pappo AS; Furman WL; Schultz KA; Ferrari A; Helman L; Krailo MD
    J Clin Oncol; 2015 Sep; 33(27):3047-54. PubMed ID: 26304909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial design for rare cancers: why a less conventional route may be required.
    Panageas KS
    Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.